{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T18:40:07Z","timestamp":1733596807530,"version":"3.30.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T00:00:00Z","timestamp":1733529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T00:00:00Z","timestamp":1733529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CVIR Endovasc"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Lower limb peripheral artery disease classified as Rutherford category IV, is characterized by lower limb ischemic pain both during exertion and at rest. This disease has an unclear course. We aimed to evaluate outcome predictors in this patient group after endovascular therapy. This single-center, retrospective, observational study included 234 consecutive patients (264 limbs), between April 2007 and December 2020. We investigated the disease clinical course after endovascular therapy. The primary endpoint was the wound formation rate 3\u00a0years after endovascular therapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The mean observation period was 48.2\u2009\u00b1\u20098.9\u00a0months. The patients (61.9% male; mean age, 76\u2009\u00b1\u200910\u00a0years) presented with diabetes (64.1%), and received hemodialysis with chronic kidney disease (35.0%) and ambulatory treatment (85.0%). The average ankle-brachial index before endovascular therapy was 0.69\u2009\u00b1\u20090.23. Skin perfusion pressure on the dorsal and plantar sides was 38\u2009\u00b1\u200913\u00a0mmHg and 36\u2009\u00b1\u200912\u00a0mmHg, respectively. The wound incidence rates at 1, 2, and 3\u00a0years after endovascular therapy were 8.3%, 11.4%, and 14.4%, respectively. Multivariate analysis revealed the following factors associated with wound formation: P2 in inframalleolar\/pedal disease category in the Global Limb Anatomical Staging System (hazard ratio: 1.73, 95% confidence interval: 1.22\u20132.83, <jats:italic>P<\/jats:italic>\u2009=\u20090.01), non-ambulatory status (hazard ratio: 1.09, 95% confidence interval: 1.11\u20131.36, <jats:italic>P<\/jats:italic>\u2009=\u20090.02), intervention up to infrapopliteal lesion (hazard ratio: 1.55, 95% confidence interval: 1.17\u20132.46, <jats:italic>P<\/jats:italic>\u2009=\u20090.03), and patient with chronic kidney disease on hemodialysis (hazard ratio: 1.61, 95% confidence interval: 1.32\u20132.18, <jats:italic>P<\/jats:italic>\u2009=\u20090.03).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The 3-year incidence of wound onset in this study was 14.4%. Factors associated with this outcome included P2 in the Global Limb Anatomical Staging System, non-ambulatory status, intervention up to infrapopliteal lesion, and patient with chronic kidney disease on hemodialysis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s42155-024-00500-3","type":"journal-article","created":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T05:13:09Z","timestamp":1733548389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Wound formation in patients with Rutherford category IV disease after endovascular therapy: rates and risk factors"],"prefix":"10.1186","volume":"7","author":[{"given":"Toshihiko","family":"Kishida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,7]]},"reference":[{"key":"500_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.atherosclerosis.2016.10.039","volume":"255","author":"S Haitjema","year":"2016","unstructured":"Haitjema S, van Haelst STW, de Vries JPM, Moll FL, den Ruijter HM, de Borst GJ, et al. Time-dependent differences in femoral artery plaque characteristics of peripheral arterial disease patients. Atherosclerosis. 2016;255:66\u201372.","journal-title":"Atherosclerosis"},{"key":"500_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11886-015-0622-8","volume":"17","author":"AJ Mintz","year":"2015","unstructured":"Mintz AJ, Weinberg I. Nonatherosclerotic PAD: Approach to Exertional Pain in the Lower Extremities. Curr Cardiol Rep. 2015;17:66.","journal-title":"Curr Cardiol Rep"},{"key":"500_CR3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3889\/oamjms.2018.035","volume":"6","author":"U Wollina","year":"2018","unstructured":"Wollina U, Koch A, Langner D, Heinig B, Lotti T, Tchernev G. Acrocyanosis \u2013 A Symptom with Many Facettes. Open Access Maced J Med Sci. 2018;6:208\u201312.","journal-title":"Open Access Maced J Med Sci"},{"key":"500_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.atherosclerosis.2018.05.048","volume":"275","author":"T Ohkuma","year":"2018","unstructured":"Ohkuma T, Ninomiya T, Tomiyama H, Kario K, Hoshide S, Kita Y, et al. Ankle-Brachial index measured by oscillometry is predictive for cardiovascular disease and premature death in the Japanese population: An individual participant data meta-analysis. Atherosclerosis. 2018;275:141\u20138.","journal-title":"Atherosclerosis"},{"key":"500_CR5","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/S2214-109X(19)30255-4","volume":"7","author":"P Song","year":"2019","unstructured":"Song P, Rudan D, Zhu Y, Fowkes FJ, Rahimi K, Fowkes FG, et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019;7:1020\u201330.","journal-title":"Lancet Glob Health"},{"key":"500_CR6","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1177\/2047487312462822","volume":"21","author":"A Ishida","year":"2014","unstructured":"Ishida A, Miyagi M, Kinjo K, Ohya Y. Age- and sex-related effects on ankle-brachial index in a screened cohort of Japanese: the Okinawa Peripheral Arterial Disease (OPADS). Eur J Prev Cardiol. 2014;21:712\u20138.","journal-title":"Eur J Prev Cardiol"},{"key":"500_CR7","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.atherosclerosis.2014.03.018","volume":"234","author":"C Natsuki","year":"2014","unstructured":"Natsuki C, Inoguchi T, Maeda Y, Yamada T, Sasaki S, Sonoda N, et al. Association of borderline ankle-brachial index with mortality and the incidence of peripheral artery disease in diabetic patients. Atherosclerosis. 2014;234:360\u20135.","journal-title":"Atherosclerosis"},{"key":"500_CR8","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/S2213-8587(17)30183-3","volume":"5","author":"K Matsushita","year":"2017","unstructured":"Matsushita K, Ballew SH, Coresh J, Arima H, \u00c4rnl\u00f6v J, Cirillo M, et al. Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2017;5:718\u201328.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"500_CR9","first-page":"1885","volume":"11","author":"A Joshua","year":"2021","unstructured":"Joshua A, Peter A, Michael S. Advances in Revascularization for Peripheral Artery Disease: Revascularization in PAD. Circ Res. 2021;11:1885\u2013912.","journal-title":"Circ Res"},{"key":"500_CR10","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.jcin.2014.06.018","volume":"7","author":"Y Soga","year":"2014","unstructured":"Soga Y, Iida O, Takahara M, Hirano K, Suzuki K, Kawasaki D, et al. Two-year life expectancy in patients with critical limb ischemia. JACC Cardiovasc Interv. 2014;7:1444\u20139.","journal-title":"JACC Cardiovasc Interv"},{"key":"500_CR11","doi-asserted-by":"publisher","first-page":"205031211559708","DOI":"10.1177\/2050312115597087","volume":"3","author":"T Tsuchiya","year":"2015","unstructured":"Tsuchiya T, Iida O, Shiraki T, Soga Y, Hirano K, Suzuki K, et al. Clinical characteristics of patients with Rutherford category IV, compared with V and VI. SAGE Open Med. 2015;3:2050312115597087.","journal-title":"SAGE Open Med"},{"key":"500_CR12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ejvs.2018.01.019","volume":"55","author":"F Sartipy","year":"2018","unstructured":"Sartipy F, Sigvant B, Lundin F, Wahlberg E. Ten year mortality in different peripheral arterial disease stages: A population based observational study on outcome. Eur J Vasc Endovasc Surg. 2018;55:529\u201336.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"500_CR13","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.jvs.2015.07.065","volume":"62","author":"MW Steffen","year":"2015","unstructured":"Steffen MW, Undavalli C, Asi N, Wang Z, Elamin MB, Conte MS, et al. The natural history of untreated severe or critical limb ischemia. J Vasc Surg. 2015;62:1642\u201351.","journal-title":"J Vasc Surg"},{"key":"500_CR14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.118.006778","volume":"11","author":"Y Takeji","year":"2018","unstructured":"Takeji Y, Yamaji K, Tomoi Y, et al. Impact of Frailty on Clinical Outcomes in Patients With Critical Limb Ischemia. Circ Cardiovasc Interv. 2018;11: e006778.","journal-title":"Circ Cardiovasc Interv"},{"key":"500_CR15","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1093\/eurheartj\/ehac016","volume":"43","author":"M Lena","year":"2022","unstructured":"Lena M, Jeanette K, Christiane E, Leonie K, et al. Sex-related differences in treatment and outcome of chronic limb-threatening ischemia: a real-world cohort. Eur Heart J. 2022;43:1759\u201370.","journal-title":"Eur Heart J"},{"key":"500_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.atherosclerosis.2004.05.028","volume":"177","author":"T Fujiwara","year":"2004","unstructured":"Fujiwara T, Saitoh S, Takagi S, et al. Prevalence of asymptomatic arteriosclerosis obliterans and its relationship with risk factors in inhabitants of rural communities in Japan: Tanno-Sobetsu study. Atherosclerosis. 2004;177:83\u20138.","journal-title":"Atherosclerosis"},{"key":"500_CR17","doi-asserted-by":"crossref","unstructured":"Takahara M, Iida O, Soga Y, et al. SPINACH study investigators. Absence of Preceding Intermittent Claudication and its Associated Clinical Freatures in Patients with Critical Limb Ischemia. J Atheroscler Thromb. 2015;22:718\u2013725.","DOI":"10.5551\/jat.28217"},{"key":"500_CR18","doi-asserted-by":"crossref","unstructured":"Iida O, Takahara M, Soga Y, et al. PRIORITY Investigators. Prognostic Impact of Revascularization in Poor-Risk Patients With Critical Limb Ischemia: The PRIORITY Registry (Poor-Risk Patients With and Without Revascularization Therapy for Critical Limb Ischemia). JACC Cardiovasc Interv. 2017;10:1147\u20131157.","DOI":"10.1016\/j.jcin.2017.03.012"},{"key":"500_CR19","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.ejvs.2020.05.003","volume":"60","author":"T Tokuda","year":"2020","unstructured":"Tokuda T, Oba Y, Koshida R, et al. Prediction of the Technical Success of Endovascular Therapy in Patients with Critical Limb Threatening Ischaemia Using the Global Limb Anatomical Staging System. Eur J Vasc Endovasc Surg. 2020;60:696\u2013702.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"500_CR20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jjcc.2015.05.003","volume":"67","author":"H Ishii","year":"2016","unstructured":"Ishii H, Aoyama T, Takahashi H, et al. Treatment with cilostazol improves clinical outcome after endovascular therapy in hemodialysis patients with peripheral artery disease. J Cardiol. 2016;67:199\u2013204.","journal-title":"J Cardiol"},{"key":"500_CR21","doi-asserted-by":"crossref","unstructured":"Kumbhani DJ, Steg PG, Cannon CP, et al. REACH Registry Investigators. Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. Eur Heart J. 2014;35:2864\u20132872.","DOI":"10.1093\/eurheartj\/ehu080"},{"key":"500_CR22","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jvs.2013.08.003","volume":"59","author":"JL Mills Sr","year":"2014","unstructured":"Mills JL Sr, Conte MS, Armstrong DG, Pomposelli FB, Schanzer A, Sidawy AN, et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg. 2014;59:220-34.e1.","journal-title":"J Vasc Surg"},{"issue":"Suppl","key":"500_CR23","doi-asserted-by":"publisher","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","volume":"69","author":"MS Conte","year":"2019","unstructured":"Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69(Suppl):3S-125S.","journal-title":"J Vasc Surg"},{"key":"500_CR24","doi-asserted-by":"crossref","unstructured":"Norgren L, Hiatt WR, Dormandy JA, et al. TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45 Suppl: S5-S67.","DOI":"10.1016\/j.jvs.2006.12.037"},{"key":"500_CR25","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/ehjqcco\/qcw057","volume":"3","author":"H Kumakura","year":"2017","unstructured":"Kumakura H, Kanai H, Hojo Y, Iwasaki T, Ichikawa S. Long-term survival and fate of the leg in de novo intermittent claudication. Eur Heart J Qual Care Clin Outcomes. 2017;3:208\u201315.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"500_CR26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.ejvs.2015.10.022","volume":"51","author":"B Sigvant","year":"2016","unstructured":"Sigvant B, Lundin F, Wahlberg E. The Risk of Disease Progression in Peripheral Arterial Disease is Higher than Expected: A Meta-Analysis of Mortality and Disease Progression in Peripheral Arterial Disease. Eur J Vasc Endovasc Surg. 2016;51:395\u2013403.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"500_CR27","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.ejvs.2018.10.017","volume":"57","author":"ID van Koeverden","year":"2019","unstructured":"van Koeverden ID, Scholtes VP, den Ruijter HM, Hazenberg SC, de Kleijn DP, de Borst GJ. The impact of diabetes and time on the atherosclerotic plaque and cardiovascular outcome in patients undergoing iliofemoral endarterectomy. Eur J Vasc Endovasc Surg. 2019;57:832\u201341.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"500_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3348\/kjr.2018.19.1.47","volume":"19","author":"N Troisi","year":"2018","unstructured":"Troisi N, Turini F, Chisci E, Ercolini L, Frosini P, Lombardi R, et al. Impact of pedal arch patency on tissue loss and time to healing in diabetic patients with foot wounds undergoing infrainguinal endovascular revascularization. Korean J Radiol. 2018;19:47\u201353.","journal-title":"Korean J Radiol"},{"key":"500_CR29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.5551\/jat.61481","volume":"29","author":"M Takahara","year":"2022","unstructured":"Takahara M, Iida O, Soga Y, Azuma N, Nanto S. Clinical impact of measures for frailty severity in poor-risk patients undergoing revascularization for chronic limb-threatening ischemia. J Atheroscler Thromb. 2022;29:221\u20138.","journal-title":"J Atheroscler Thromb"},{"key":"500_CR30","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ejvs.2011.12.001","volume":"43","author":"N Azuma","year":"2012","unstructured":"Azuma N, Uchida H, Kokubo T, Koya A, Akasaka N, Sasajima T. Factors influencing wound healing of critical ischaemic foot after bypass surgery: Is the angiosome important in selecting bypass target artery? Eur J Vasc Endovasc Surg. 2012;43:322\u20138.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"500_CR31","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/ccd.24370","volume":"80","author":"O Kawarada","year":"2012","unstructured":"Kawarada O, Fujihara M, Higashimori A, Yokoi Y, Honda Y, Fitzgerald PJ. Predictors of adverse clinical outcomes after successful infrapopliteal intervention. Catheter Cardiovasc Interv. 2012;80:861\u201371.","journal-title":"Catheter Cardiovasc Interv"},{"key":"500_CR32","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.jvs.2011.01.062","volume":"53","author":"T Willenberg","year":"2011","unstructured":"Willenberg T, Baumann F, Eisenberger U, Baumgartner I, Do DD, Diehm N. Impact of renal insufficiency on clinical outcomes in patients with critical limb ischemia undergoing endovascular revascularization. J Vasc Surg. 2011;53:1589\u201397.","journal-title":"J Vasc Surg"},{"key":"500_CR33","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.jvs.2010.06.101","volume":"52","author":"E Arvela","year":"2010","unstructured":"Arvela E, S\u00f6derstr\u00f6m M, Korhonen M, Halmesm\u00e4ki K, Alb\u00e4ck A, Lep\u00e4ntalo M, et al. Finnvasc score and modified Prevent III score predict long-term outcome after infrainguinal surgical and endovascular revascularization for critical limb ischemia. J Vasc Surg. 2010;52:1218\u201325.","journal-title":"J Vasc Surg"},{"key":"500_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.7748\/ns.2021.e11740","volume":"37","author":"C Greenwood","year":"2022","unstructured":"Greenwood C. Heel pressure ulcers: Understanding why they develop and how to prevent them. Nurs Stand. 2022;37:60\u20136.","journal-title":"Nurs Stand"},{"key":"500_CR35","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1177\/1708538116673015","volume":"25","author":"Y Honda","year":"2017","unstructured":"Honda Y, Hirano K, Yamawaki M, Mori S, Shirai S, Makino K, et al. Wound healing of critical limb ischemia with tissue loss in patients on hemodialysis. Vascular. 2017;25:272\u201382.","journal-title":"Vascular"},{"key":"500_CR36","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ejvs.2011.11.025","volume":"43","author":"O Iida","year":"2012","unstructured":"Iida O, Soga Y, Hirano K, Kawasaki D, Suzuki K, Miyashita Y, et al. Midterm outcomes and risk stratification after endovascular therapy for patients with critical limb ischaemia due to isolated below-the-knee lesions. Eur J Vasc Endovasc Surg. 2012;43:313\u201321.","journal-title":"Eur J Vasc Endovasc Surg"}],"container-title":["CVIR Endovascular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42155-024-00500-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42155-024-00500-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42155-024-00500-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T18:02:40Z","timestamp":1733594560000},"score":1,"resource":{"primary":{"URL":"https:\/\/CVIRendovasc.springeropen.com\/articles\/10.1186\/s42155-024-00500-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,7]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["500"],"URL":"https:\/\/doi.org\/10.1186\/s42155-024-00500-3","relation":{},"ISSN":["2520-8934"],"issn-type":[{"type":"electronic","value":"2520-8934"}],"subject":[],"published":{"date-parts":[[2024,12,7]]},"assertion":[{"value":"15 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study complied with the Declaration of Helsinki and was approved by the hospital ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval statement"}},{"value":"We posted information about this study on our hospital website and gave participants the opportunity to opt out; those who did not were considered to have provided tacit consent for study participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}